Clinical Trial Update: Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Nilotinib with combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia or blast-ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia
• Blast Phase Chronic Myeloid Leukemia
• Chronic Myeloid Leukemia Bcr-abl1 Positive
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Mayo Clinic | Conditions: B-cell Adult Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia | Phase 2 | Status: WITHDRAWN